SOPs for BA-BE Studies V 2.0

To define the procedure for screening and selecting healthy volunteers for participation in Bioavailability/Bioequivalence (BA/BE) studies, ensuring subject safety and compliance with ethical and regulatory requirements.
Click to read the full article.

To define the procedure for enrolling eligible subjects and allocating them to treatment sequences using a pre-approved and validated randomization process in Bioavailability/Bioequivalence (BA/BE) studies.
Click to read the full article.

To define a standardized procedure for documenting the past and present medical history of healthy volunteers in Bioavailability/Bioequivalence (BA/BE) studies, to support proper eligibility assessment and ensure subject safety.
Click to read the full article.

To outline the procedure for obtaining and documenting informed consent from healthy volunteers prior to participation in any Bioavailability/Bioequivalence (BA/BE) study-related procedures, in accordance with ICH-GCP, Schedule Y, and ethical standards.
Click to read the full article.

To define the procedure for conducting a standardized physical examination of healthy volunteers prior to administration of investigational or reference products in Bioavailability/Bioequivalence (BA/BE) studies, ensuring the subject is clinically fit for dosing.
Click to read the full article.

To define the procedure for conducting and documenting electrocardiogram (ECG) monitoring of healthy volunteers prior to dosing in Bioavailability/Bioequivalence (BA/BE) studies to evaluate cardiac health and ensure subject safety.
Click to read the full article.

To define the procedure for performing and documenting laboratory safety tests on healthy volunteers before dosing in Bioavailability/Bioequivalence (BA/BE) studies, ensuring that only eligible and healthy participants proceed to drug administration.
Click to read the full article.

To establish a standard procedure for scheduling and enforcing the pre-dose fasting period for study participants in Bioavailability/Bioequivalence (BA/BE) studies to ensure valid pharmacokinetic evaluations and adherence to protocol.
Click to read the full article.

To establish a standardized procedure for administering the investigational product (IP) under fed conditions to healthy volunteers in Bioavailability/Bioequivalence (BA/BE) studies as per protocol, regulatory, and GCP requirements.
Click to read the full article.

To define a standardized procedure for administering the study drug under fasting conditions in Bioavailability/Bioequivalence (BA/BE) studies, ensuring accurate pharmacokinetic assessment and regulatory compliance.
Click to read the full article.